Canlyniadau Chwilio - Yibing Yan
- Dangos 1 - 20 canlyniadau o 32
- Ewch i'r Dudalen Nesaf
-
1
Engineering of betabellin 14D: Disulfide‐induced folding of a β‐sheet protein gan Yibing Yan, Bruce W. Erickson
Cyhoeddwyd 1994Artigo -
2
-
3
-
4
-
5
-
6
-
7
Proteomic analysis of breast cancer molecular subtypes and biomarkers of response to targeted kinase inhibitors using reverse-phase protein microarrays gan Zachary Boyd, Qun Wu, Carol O’Brien, Jill M. Spoerke, Heidi Savage, Paul J. Fielder, Lukas C. Amler, Yibing Yan, Mark R. Lackner
Cyhoeddwyd 2008Artigo -
8
Endothelial expression of constitutively active <i>Notch4</i> elicits reversible arteriovenous malformations in adult mice gan Timothy R. Carlson, Yibing Yan, Xiaoqing Wu, Michael T. Lam, Gale L. Tang, Levi J. Beverly, Louis M. Messina, Anthony J. Capobianco, Zena Werb, Rong Wang
Cyhoeddwyd 2005Artigo -
9
Network quantification of EGFR signaling unveils potential for targeted combination therapy gan Bertram Klinger, Anja Sieber, Raphaela Fritsche‐Guenther, Franziska Witzel, Leanne Berry, Dirk Schumacher, Yibing Yan, Pawel Durek, Mark Merchant, Reinhold Schäfer, Christine Sers, Nils Blüthgen
Cyhoeddwyd 2013Artigo -
10
Development and validation of a machine learning-based predictive model for assessing the 90-day prognostic outcome of patients with spontaneous intracerebral hemorrhage gan Zhi Geng, Chaoyi Yang, Zi‐Ye Zhao, Yibing Yan, Tao Guo, Chaofan Liu, Aimei Wu, Xingqi Wu, Ling Wei, Yanghua Tian, Panpan Hu, Kai Wang
Cyhoeddwyd 2024Artigo -
11
Accelerated intermittent theta-burst stimulation broadly ameliorates symptoms and cognition in Alzheimer's disease: A randomized controlled trial gan Xingqi Wu, Gong‐Jun Ji, Zhi Geng, Lu Wang, Yibing Yan, Yue Wu, Guixian Xiao, Liying Gao, Qiang Wei, Shanshan Zhou, Ling Wei, Yanghua Tian, Kai Wang
Cyhoeddwyd 2021Artigo -
12
High-Throughput Detection of Clinically Relevant Mutations in Archived Tumor Samples by Multiplexed PCR and Next-Generation Sequencing gan Richard Bourgon, Shan Lu, Yibing Yan, Mark R. Lackner, Weiru Wang, Victor Weigman, David Wang, Yinghui Guan, Lisa Ryner, Hartmut Koeppen, Rajesh Patel, Garret M. Hampton, Lukas C. Amler, Yulei Wang
Cyhoeddwyd 2014Artigo -
13
Effects of a periodic intermittent theta burst stimulation in Alzheimer’s disease gan Xingqi Wu, Yibing Yan, Panpan Hu, Lu Wang, Yue Wu, Pan Wu, Zhi Geng, Guixian Xiao, Shanshan Zhou, Gong‐Jun Ji, Bensheng Qiu, Ling Wei, Yanghua Tian, Hesheng Liu, Kai Wang
Cyhoeddwyd 2024Artigo -
14
Looking at proteins: representations, folding, packing, and design. Biophysical Society National Lecture, 1992 gan Jane S. Richardson, David Richardson, Neil B. Tweedy, Kimberly Gernert, Thomas P. Quinn, Michael H. Hecht, Bruce W. Erickson, Yibing Yan, Robert L. McClain, Mary Donlan, Mark C. Surles, Mark C. Surles
Cyhoeddwyd 1992Artigo -
15
Extended 5-Year Follow-up Results of a Phase Ib Study (BRIM7) of Vemurafenib and Cobimetinib in <i>BRAF</i>-Mutant Melanoma gan Antoni Ribas, Adil Daud, Anna C. Pavlick, René González, Karl D. Lewis, Omid Hamid, Thomas F. Gajewski, Igor Puzanov, Matthew Wongchenko, Isabelle Rooney, Jessie J. Hsu, Yibing Yan, Erica Park, Grant A. McArthur
Cyhoeddwyd 2019Artigo -
16
307 Atezolizumab plus vemurafenib and cobimetinib provides favorable survival outcomes in patients with high tumor mutation burden and proinflammatory gene signature in the phase 3... gan Karl D. Lewis, Paolo A. Ascierto, Caroline Robert, Rodrigo Ramella Munhoz, Gabriella Liszkay, Luis De La Cruz Marino, Judit Oláh, Paola Queirolo, Jacek Mackiewicz, Kalpit Shah, Harper Forbes, Christian Hertig, Yibing Yan, Ralf Gutzmer, Grant A. McArthur
Cyhoeddwyd 2020Artigo -
17
Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors gan Timothy R. Wilson, Jane Fridlyand, Yibing Yan, Elicia Penuel, Luciana Burton, Emily Chan, Jing Peng, Eva Lin, Yulei Wang, Jeff Sosman, Antoni Ribas, Li Jiang, John G. Moffat, Daniel P. Sutherlin, Hartmut Koeppen, Mark Merchant, Richard M. Neve, Jeff Settleman
Cyhoeddwyd 2012Artigo -
18
P21-Activated Kinase 1 (PAK1) as a Therapeutic Target in BRAF Wild-Type Melanoma gan Christy C. Ong, Adrian M. Jubb, Diana Jakubiak, Wei Zhou, Joachim Rudolph, Peter M. Haverty, Marcin Kowanetz, Yibing Yan, Jarrod R. Tremayne, Richard J. Lisle, Adrian L. Harris, Lori S. Friedman, Marcia Belvin, Mark R. Middleton, Elizabeth M. Blackwood, Hartmut Koeppen, Klaus P. Hoeflich
Cyhoeddwyd 2013Artigo -
19
Critical role for Syk in responses to vascular injury gan Patrick André, Toshifumi Morooka, Derek Sim, Keith Abe, Clifford A. Lowell, Nisha Nanda, Suzanne M. Delaney, Gail Siu, Yibing Yan, Stan Hollenbach, Anjali Pandey, Huiyun Gao, Yunmei Wang, Kohsuke Nakajima, Sahil A. Parikh, Can Shi, David R. Phillips, Whyte G. Owen, Uma Sinha, Daniel I. Simon
Cyhoeddwyd 2011Artigo -
20
Distinct Molecular Profiles and Immunotherapy Treatment Outcomes of V600E and V600K <i>BRAF</i>-Mutant Melanoma gan Inês Pires da Silva, Kevin Wang, James S. Wilmott, Jeff Holst, Matteo S. Carlino, John Park, Camelia Quek, Matthew Wongchenko, Yibing Yan, Graham J. Mann, Douglas B. Johnson, Jennifer L. McQuade, Rajat Rai, Richard Kefford, Helen Rizos, Richard A. Scolyer, Jean Yang, Georgina V. Long, Alexander M. Menzies
Cyhoeddwyd 2019Artigo
Offerynnau Chwilio:
Pynciau Perthynol
Biology
Medicine
Cancer research
Cancer
Internal medicine
Signal transduction
Biochemistry
Cell biology
Genetics
Gene
Oncology
Melanoma
Metastatic melanoma
Vemurafenib
Kinase
Receptor
Chemistry
Colorectal cancer
Immunology
Immunotherapy
MAPK/ERK pathway
PI3K/AKT/mTOR pathway
Protein kinase B
Computational biology
Confidence interval
Hazard ratio
KRAS
Metastasis
Mutation
Pharmacology